Caesar J. Belbel
2013
In 2013, Caesar J. Belbel earned a total compensation of $912.4K as Executive Vice President, Chief Legal Officer and Secretary at ZIOPHARM Oncology, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $61,250 |
|---|---|
| Option Awards | $500,340 |
| Salary | $350,000 |
| Other | $828 |
| Total | $912,418 |
Belbel received $500.3K in option awards, accounting for 55% of the total pay in 2013.
Belbel also received $61.3K in bonus, $350K in salary and $828 in other compensation.
Rankings
In 2013, Caesar J. Belbel's compensation ranked 7,047th out of 12,286 executives tracked by ExecPay. In other words, Belbel earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,047 out of 12,286 | 43rd |
Division Manufacturing | 2,510 out of 4,612 | 46th |
Major group Chemicals And Allied Products | 772 out of 1,466 | 47th |
Industry group Drugs | 573 out of 1,160 | 51st |
Industry Pharmaceutical Preparations | 456 out of 890 | 49th |
Source: SEC filing on April 30, 2014.
Belbel's colleagues
We found four more compensation records of executives who worked with Caesar J. Belbel at ZIOPHARM Oncology in 2013.